25/06/2025
🎯 NHS backs Mounjaro — but is this really how we fix obesity?
With over half of adults predicted to be overweight or obese by 2050 (The Lancet), the NHS is now turning to 'skinny' jabs in a bid to stem the crisis. But are we trading one public health problem for another?
While such drugs can lead to short-term weight loss, they come with serious risks:
⚠️ Muscle loss
⚠️ Pancreatitis
⚠️ Thyroid cancer concerns
⚠️ Crushing fatigue
⚠️ Weight regain after stopping
Worse still, patients often aren’t told about safer, sustainable alternatives — like fasting, nutrient-dense eating, strength training, and addressing emotional triggers.
This shift toward medicating obesity reflects a deeper issue: Big Pharma profits from quick fixes while the root causes of metabolic dysfunction go ignored.
📢 It’s time for informed consent, real education, and natural approaches that empower people — not trap them in lifelong drug dependency. Link to read more or listen to the article 👇